BioXcel Therapeutics, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Peter Mueller. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Peter Mueller har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:BTAI / BioXcel Therapeutics, Inc. Director 17.000
US:VRTX / Vertex Pharmaceuticals Incorporated EVP, Global R&D, CSO 15.500
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Peter Mueller. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BTAI / BioXcel Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BTAI / BioXcel Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-08-23 BTAI MUELLER PETER 1.554 9,3400 97 149,4400 14.514 334 64.63 -8.245 -56,81
2019-08-22 BTAI MUELLER PETER 6.646 8,8300 415 141,2800 58.684
2019-08-21 BTAI MUELLER PETER 1.800 8,4200 112 134,7200 15.156
2018-12-07 BTAI MUELLER PETER 495 5,0000 31 80,0000 2.475
2018-12-07 BTAI MUELLER PETER 6.905 5,0100 432 80,1600 34.594
2018-12-06 BTAI MUELLER PETER 1.295 5,0000 81 80,0000 6.475
2018-12-06 BTAI MUELLER PETER 100 5,0100 6 80,1600 501
2018-12-04 BTAI MUELLER PETER 1.076 5,0900 67 81,4400 5.477
2018-12-04 BTAI MUELLER PETER 325 5,1100 20 81,7600 1.661
2018-12-04 BTAI MUELLER PETER 344 5,1200 22 81,9200 1.761
2018-12-04 BTAI MUELLER PETER 200 5,1300 12 82,0800 1.026
2018-12-04 BTAI MUELLER PETER 2.062 5,1500 129 82,4000 10.619

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BTAI / BioXcel Therapeutics, Inc. Insider Trades
Insidersalg BTAI / BioXcel Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BTAI / BioXcel Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BTAI / BioXcel Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Peter Mueller som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-05-23 2022-05-19 4 BTAI BioXcel Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 17.000 17.000
2021-06-15 2021-06-11 4 BTAI BioXcel Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14.500 14.500
2020-05-26 2020-05-21 4 BTAI BioXcel Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 5.000 5.000
2020-05-26 2020-05-21 4 BTAI BioXcel Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2020-02-14 2018-07-02 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
G - Gift 90.000 90.000
2020-02-14 2018-07-02 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
G - Gift -90.000 119.795 -42,90
2020-02-14 3/A BTAI BioXcel Therapeutics, Inc.
Common Stock
209.795
2019-08-26 2019-08-23 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 1.554 168.320 0,93 9,34 14.514 1.572.109
2019-08-23 2019-08-22 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 6.646 166.766 4,15 8,83 58.684 1.472.544
2019-08-23 2019-08-21 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 1.800 160.120 1,14 8,42 15.156 1.348.210
2019-05-28 2019-05-23 4 BTAI BioXcel Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14.700 14.700
2018-12-07 2018-12-07 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 6.905 158.320 4,56 5,01 34.594 793.183
2018-12-07 2018-12-07 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 495 151.415 0,33 5,00 2.475 757.075
2018-12-07 2018-12-06 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 100 150.920 0,07 5,01 501 756.109
2018-12-07 2018-12-06 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 1.295 150.820 0,87 5,00 6.475 754.100
2018-12-06 2018-12-04 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 2.062 149.525 1,40 5,15 10.619 770.054
2018-12-06 2018-12-04 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 200 147.463 0,14 5,13 1.026 756.485
2018-12-06 2018-12-04 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 344 147.263 0,23 5,12 1.761 753.987
2018-12-06 2018-12-04 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 325 146.919 0,22 5,11 1.661 750.756
2018-12-06 2018-12-04 4 BTAI BioXcel Therapeutics, Inc.
Common Stock
P - Purchase 1.076 146.594 0,74 5,09 5.477 746.163
2018-03-13 2018-03-12 4 BTAI BioXcel Therapeutics, Inc.
Stock Options
A - Award 37.209 161.397 29,96
2018-03-07 3 BTAI BioXcel Therapeutics, Inc.
Common Stock
291.036
2018-03-07 3 BTAI BioXcel Therapeutics, Inc.
Common Stock
291.036
2014-06-18 2014-06-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7.500 15.500 -32,61
2014-06-18 2014-06-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.000 143.517 -0,69 70,29 -70.290 10.087.810
2014-06-18 2014-06-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -597 144.517 -0,41 69,54 -41.515 10.049.712
2014-06-18 2014-06-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.500 145.114 -1,02 68,25 -102.375 9.904.030
2014-06-18 2014-06-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.403 146.614 -2,92 67,72 -298.171 9.928.700
2014-06-18 2014-06-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 151.017 5,23 32,16 241.200 4.856.707
2014-05-16 2014-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7.500 23.000 -24,59
2014-05-16 2014-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 143.517 -0,42 68,08 -40.848 9.770.637
2014-05-16 2014-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.400 144.117 -4,25 67,49 -431.936 9.726.456
2014-05-16 2014-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 150.517 -0,33 66,13 -33.065 9.953.689
2014-05-16 2014-05-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 151.017 5,23 32,16 241.200 4.856.707
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (righty to buy)
M - Exercise -5.750 30.500 -15,86
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -1.750 0 -100,00
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 158.750 -0,44 63,27 -44.289 10.044.112
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.800 159.450 -1,12 62,38 -112.284 9.946.491
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.900 161.250 -1,77 61,53 -178.437 9.921.712
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.100 164.150 -1,26 60,57 -127.197 9.942.566
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.750 166.250 3,58 32,16 184.920 5.346.600
2014-04-17 2014-04-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.750 160.500 1,10 28,84 50.470 4.628.820
2014-03-19 2014-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7.500 1.750 -81,08
2014-03-19 2014-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.220 158.750 -0,76 78,78 -96.112 12.506.325
2014-03-19 2014-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.280 159.970 -3,78 78,19 -491.033 12.508.054
2014-03-19 2014-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 166.250 4,72 28,84 216.300 4.794.650
2014-02-20 2014-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7.500 9.250 -44,78
2014-02-20 2014-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -633 158.750 -0,40 83,05 -52.571 13.184.188
2014-02-20 2014-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.867 159.383 -4,13 82,55 -566.871 13.157.067
2014-02-20 2014-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 166.250 4,72 28,84 216.300 4.794.650
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 51.000 51.000
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 17.250 158.750 12,19 0,01 172 1.588
2014-01-17 2014-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7.500 16.750 -30,93
2014-01-17 2014-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.500 141.500 -5,03 78,67 -590.025 11.131.805
2014-01-17 2014-01-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 149.000 5,30 28,84 216.300 4.297.160
2013-12-17 2013-12-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7.500 24.250 -23,62
2013-12-17 2013-12-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.100 141.500 -1,46 65,42 -137.382 9.256.930
2013-12-17 2013-12-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.400 143.600 -3,62 64,40 -347.760 9.247.840
2013-12-17 2013-12-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 149.000 5,30 28,84 216.300 4.297.160
2013-12-12 2013-12-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.900 141.500 -2,01 65,48 -189.892 9.265.420
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -4.500 31.750 -12,41
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -3.000 0 -100,00
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.200 144.400 -1,50 63,12 -138.864 9.114.528
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.200 146.600 -2,79 62,62 -263.004 9.180.092
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.100 150.800 -0,72 61,58 -67.738 9.286.264
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.000 151.900 2,01 18,93 56.790 2.875.467
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.500 148.900 3,12 28,84 129.780 4.294.276
2013-10-17 2013-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -7.500 3.000 -71,43
2013-10-17 2013-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -666 144.400 -0,46 73,85 -49.184 10.663.940
2013-10-17 2013-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.834 145.066 -4,50 73,19 -500.180 10.617.381
2013-10-17 2013-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 151.900 5,19 18,93 141.975 2.875.467
2013-09-17 2013-09-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -7.500 10.500 -41,67
2013-09-17 2013-09-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 144.400 -0,14 79,08 -15.816 11.419.152
2013-09-17 2013-09-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.320 144.600 -0,90 78,38 -103.462 11.333.748
2013-09-17 2013-09-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.895 145.920 -1,95 77,44 -224.189 11.300.045
2013-09-17 2013-09-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.085 148.815 -2,03 76,40 -235.694 11.369.466
2013-09-17 2013-09-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 151.900 5,19 18,93 141.975 2.875.467
2013-08-19 2013-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -7.500 18.000 -29,41
2013-08-19 2013-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.000 144.400 -2,04 77,93 -233.790 11.253.092
2013-08-19 2013-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.500 147.400 -2,96 77,06 -346.770 11.358.644
2013-08-19 2013-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 151.900 5,19 18,93 141.975 2.875.467
2013-08-01 2013-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 34.000 34.000
2013-07-17 2013-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -7.500 25.500 -22,73
2013-07-17 2013-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.535 144.400 -1,73 86,66 -219.683 12.513.704
2013-07-17 2013-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.965 146.935 -3,27 86,17 -427.834 12.661.389
2013-07-17 2013-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 151.900 5,19 18,93 141.975 2.875.467
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -7.500 33.000 -18,52
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -9.800 0 -100,00
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -105.000 195.000 -35,00
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -39.365 144.400 -21,42 80,58 -3.172.032 11.635.752
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -68.985 183.765 -27,29 79,52 -5.485.687 14.612.993
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -13.950 252.750 -5,23 78,94 -1.101.213 19.952.085
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.500 266.700 2,89 18,93 141.975 5.048.631
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9.800 259.200 3,93 16,32 159.936 4.230.144
2013-07-03 2013-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 105.000 249.400 72,71 33,00 3.465.000 8.230.200
2013-05-20 2013-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
G - Gift -10.352 0 -100,00
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 54.375 54.375
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.084 144.400 9,13 0,01 121 1.444
2012-10-16 2012-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option Grant (right to buy)
M - Exercise -6.500 9.800 -39,88
2012-10-16 2012-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.000 132.316 -1,49 53,14 -106.280 7.031.272
2012-10-16 2012-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.500 134.316 -3,24 52,83 -237.735 7.095.914
2012-10-16 2012-10-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.500 138.816 4,91 16,32 106.080 2.265.477
2012-09-19 2012-09-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option Grant (right to buy)
M - Exercise -6.500 16.300 -28,51
2012-09-19 2012-09-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.500 132.316 -4,68 57,52 -373.880 7.610.816
2012-09-19 2012-09-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.500 138.816 4,91 16,32 106.080 2.265.477
2012-08-17 2012-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option Grant (right to buy)
M - Exercise -6.500 22.800 -22,18
2012-08-17 2012-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.100 132.316 -3,01 54,30 -222.630 7.184.759
2012-08-17 2012-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.400 136.416 -1,73 53,84 -129.216 7.344.637
2012-08-17 2012-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.500 138.816 4,91 16,32 106.080 2.265.477
2012-07-26 2012-07-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 36.250 36.250
2012-07-18 2012-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option Grant (right to buy)
M - Exercise -6.500 29.300 -18,16
2012-07-18 2012-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.500 132.316 -1,85 53,24 -133.100 7.044.504
2012-07-18 2012-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.000 134.816 -2,88 52,49 -209.960 7.076.492
2012-07-18 2012-07-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.500 138.816 4,91 16,32 106.080 2.265.477
2012-06-19 2012-06-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option Grant (right to buy)
M - Exercise -6.500 35.800 -15,37
2012-06-19 2012-06-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.500 132.316 -4,68 56,37 -366.405 7.458.653
2012-06-19 2012-06-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.500 138.816 4,91 16,32 106.080 2.265.477
2012-05-16 2012-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -6.500 42.300 -13,32
2012-05-16 2012-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 132.316 -0,53 65,50 -45.850 8.666.698
2012-05-16 2012-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.700 133.016 -2,71 64,30 -237.910 8.552.929
2012-05-16 2012-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.100 136.716 -1,51 63,84 -134.064 8.727.949
2012-05-16 2012-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.500 138.816 4,91 16,32 106.080 2.265.477
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -25.000 40.500 -38,17
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -51.200 48.800 -51,20
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -3.300 0 -100,00
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -25.000 148.236 -14,43 55,00 -1.375.000 8.152.980
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -54.500 173.236 -23,93 52,13 -2.841.085 9.030.793
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 25.000 227.736 12,33 18,93 473.250 4.311.042
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 51.200 202.736 33,79 16,32 835.584 3.308.652
2012-05-09 2012-05-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.300 151.536 2,23 11,27 37.191 1.707.811
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 72.500 72.500
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14.501 148.236 10,84 0,01 145 1.482
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)